Under New CEO, Henry Schein Stops Just Distributing and Starts Building a Practice Improvement Platform
HSIC's second quarter shows accelerating dental merch, a $200M value-creation engine, and a cloud/AI stack that the tape is starting to re-rate.
HSIC · Earnings Call · 2026-08-04
A New Operating Playbook Takes Shape
Fred Lowery, three months into the CEO seat at Henry Schein, used his second earnings call to frame the distribution giant as something more than a supplier. "Henry Schein has great assets and capabilities, and our customer reach is really unmatched," he said, adding that his early stakeholder conversations have strengthened conviction that there is "significant opportunity to improve our revenue growth and improve our profitability." “And they see Henry Schein as a reliable business partner due to our consistent execution, our product quality and our responsiveness.” — Frederick Lowery, Chief Executive Officer · 2026-08-04 That is an explicit move to repaint the company as a practice improvement platform rather than a low-growth distribution curve. The plan has a dollar figure attached. The company reiterated its target of at least $200 million in operating income improvements from value creation initiatives over the next few years, with a $125 million run-rate by end-2026. Ron South broke down the 2026 split: roughly 40% from gross-profit initiatives and 60% from G&A savings. The first concrete step is a global outsourcing provider for finance and customer service, which the company expects to deliver "more than half of the G&A savings in our $200 million goal" “we're now engaging a third party to help us with... globally calling our global business services” — Frederick Lowery, Chief Executive Officer · 2026-08-04. The CFO was careful to note that guidance are a range, not a promise: "our guidance takes into account a range of potential outcomes" “But we -- we still believe that we have a good track to achieve that run rate of $125 million of operating income improvements as we exit 2026” — Ronald South, Senior Vice President and Chief Financial Officer · 2026-08-04. This is a coordinated reinvestment story, not just a cost-out program. In Q&A, Lowery clarified that the internal name for the effort is "value creation for growth" — a signal that the margin expansion is meant to fund share gains in accelerate growth areas like technology and specialty.The Technology Stack Is the Bull Case
The most company-specific developments sit in Henry Schein One, the software arm. The company now counts almost 13,000 subscribers on its Dentrix Ascend and Dentally cloud platforms, and it's embedding AI features — voice-enabled clinical notes, insurance eligibility analysis, claims and collections — that management argues add real productivity to dental practices. "These new capabilities help to drive productivity for private practice, for group practices and for DSOs" “As dental practice labor costs continue to rise, our customers are looking to Henry Schein to help them operate more efficiently” — Frederick Lowery, Chief Executive Officer · 2026-08-04. The recent launch of a next-generation AI clinical workflow is "met with strong market reception." The most forward-looking disclosure was about an MCP layer — a connector that lets practices query their own data with AI agents. Lowery called it a coming launch that will let customers "identify revenue opportunities as well as to drive further operational efficiencies in a targeted manner." That's a direct step toward turning PMS system into a monetizable, agentic data layer. Equally telling: the monthly revenue per customer for Dentrix Ascend is about $800 versus ~$500 for the broader Henry Schein One base. As customers upgrade packages, that recurring revenue becomes a powerful cross-sell into the merchandise side. Management says it hasn't yet publicly connected the dots between software users and distribution share of wallet — but that is clearly the direction.The Guidance Raise and the Tariff Caveat
The headline out of the quarter was a raise to full-year 2026 guidance: total sales growth now 4.5–5.5% (up from 3–5%), and non-GAAP EPS of $5.29–$5.39 (up from $5.23–$5.37). That's on the back of 4.6% internal local-currency sales growth in Q2, with U.S. dental merchandise up 8.3% (6.5% internal) and a record month for new Dentrix Ascend customers in June. Still, management was disciplined about externalities. The guidance explicitly excludes any future benefits from benefit from IEEPA tariff refunds, and it assumes no additional remeasurement gains after the $11 million recorded in Q1. That conservative framing appears designed to isolate underlying earnings power — a contrast to some peers who are booking tariff-refund windfalls. The company's own fundamentals show why that discipline matters: operating margin has been in a slow sector-wide drift, with operating margin stuck near 5% for the past two years, and the company's value-creation program is intended to lift it from here.The Tape Buying the Turn
The market has started to reward the message. HSIC is up about 17.5% over the last 90 trading days, a steady climb rather than a spike, and the full-history trend shows the stock has been in a broad up-trend since 2020 with a modest drawdown from its 2022 peak. The recent 90-day move is a fresh leg higher, timed exactly with the new CEO's first two calls. The prior CEO, Stanley Bergman, had already handed the baton with a 2026-05-05 call in which Lowery warned "we are building real capability that will stay with us over a long period of time" for value creation “We're building real capability that will stay with us over a long period of time” — Frederick Lowery, Chief Executive Officer · 2026-05-05. Even in February, Bergman said: "It is a positive environment from a market point of view" “It is a positive environment from a market point of view” — Stanley Bergman, Chairman of the Board and Chief Executive Officer · 2026-02-24. The new piece is the AI software platform, which gives the company a moat in the dental adjacency it hasn't fully monetized. As one analyst noted, the easy math on value creation alone implies double-digit EBIT growth — and consensus only penciled in $10M of second-half EBIT growth. That mismatch is now front and center.That quote came in response to a question about the new executive management committee, and it captures the operational thesis: fewer layers, closer to the customer, faster decisions. If the company can execute on that while rolling out AI to thousands of dental practices, the re-rating might be just beginning. For now, the evidence — raised guidance, accelerating internal growth, a new leadership team, and a software story with an agentic hook — suggests Henry Schein is not the same distribution company it was a year ago.We removed the layer, which puts me a little closer to the business. We integrated our supply chain more deeply into our distribution business, which puts us closer to the customer.